What’s Next? A Guide to Second-Line and Emerging Treatments for HR+/HER2- Metastatic Breast Cancer
Treatment for hormone receptor–positive (HR-positive)/HER2-negative metastatic breast cancer often starts with hormone therapy (tamoxifen or an aromatase inhibitor) and a CDK 4/6 inhibitor.e60dc2a1-f33c-4a05-9b50-8e3e8e5976298c541cc9-7684-4cb9-bcbc-f016dc060bb0 But it doesn’t always end there. At…